Carina Biotech
Blood & Organ Banks · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Catherine Helen Spence Bldg, 5 Unisa L, ...Phone Number
+61 418160425Website
www.carinabiotech.comRevenue
<$5 MillionIndustry
About Carina Biotech
Carina Biotech is dedicated to combating cancer through innovative CAR-T technologies, specifically targeting solid tumors such as advanced colorectal cancer. The company empowers patients by developing next-generation CAR-T therapies and has a proprietary multifunctional chemokine receptor platform. With a focus on advanced manufacturing processes, Carina Biotech is at the forefront of CAR-T therapy advancements. Their intended clients include patients suffering from cancer and healthcare professionals seeking cutting-edge treatment options.Explore more
Carina Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Carina Biotech
Compare insights from companies similar to Carina Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Carina Biotech
<$5M
1-10
Private
-
2016
SB
Simon BarryChief Technology Officer, Car-T Platform Technologies & Gmp
Carina Biotech Tech Stack
A closer look at the technologies used by Carina Biotech
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Carina Biotech
Sign Up For FreeTo access detailed company insights
Carina Biotech is dedicated to combating cancer through innovative CAR-T technologies, specifically targeting solid tumors such as advanced colorectal cancer. The company empowers patients by developing next-generation CAR-T therapies and has a proprietary multifunctional chemokine receptor platform. With a focus on advanced manufacturing processes... Read More
